Sphingosine kinase signalling in immune cells

Clinical and Experimental Pharmacology and Physiology

Volumn 32, Issue 3, 2005, Pages 153-161

  Kee, Tay Hwee ^a   Vit, Patricia ^a   Melendez, Alirio J ^a,b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b Department of Physiology ^*  (Singapore)

Author keywords

Immune cells; Inflammation; Lymphocytes; Mast cells; Monocytes macrophages; Neutrophils; Signalling; Sphingosine kinase; Sphingosine 1 phosphate

Indexed keywords

CERAMIDE; CHEMOKINE; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; FC RECEPTOR; HORMONE; LYMPHOCYTE ANTIGEN RECEPTOR; PHORBOL ESTER; PROTEIN KINASE INHIBITOR; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE; SPHINGOSINE KINASE; SPHINGOSINE KINASE INHIBITOR; UNCLASSIFIED DRUG;

CALCIUM TRANSPORT; CELL DIFFERENTIATION; CELL GROWTH; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; DRUG DESIGN; ENZYME ACTIVITY; GENETIC CONSERVATION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; MAST CELL; MONOCYTE; NEUTROPHIL; NONHUMAN; PHOSPHORYLATION; PHYSIOLOGY; SECOND MESSENGER; SHORT SURVEY; SIGNAL TRANSDUCTION;

ANIMALS; HUMANS; IMMUNE SYSTEM; LYMPHOCYTES; LYSOPHOSPHOLIPIDS; MAST CELLS; MONOCYTES; NEUTROPHILS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); SIGNAL TRANSDUCTION; SPHINGOSINE;

EID: 15244341285     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2005.04166.x     Document Type: Short Survey

References (121)

1. 32 into the phospholipids of pancreas slices. J. Biol. Chem. 1953; 203: 967-77.
2. Raben DM, Jarpe MB, Leach KL. Nuclear lipid metabolism in NEST: Nuclear envelope signal transduction. J. Membr. Biol. 1994; 142: 1-7.
3. Thudieum JLW. A Treatise on the Chemical Constituents of the Brain. London: Bailliere.
4. Spiegel S, Milstien S. Sphingoid bases and phospholipase D activation. J. Membr. Biol. 1995; 146: 225-37.
5. Hannun YA. The sphingomyelin cycle and the second messenger functions of ceramide. J. Biol. Chem. 1994; 269: 3125-8.
6. Heller RA, Krönke M. Tumor necrosis factor receptor-mediated signaling pathways. J. Cell Biol. 1994; 126: 5-9.
7. Kolesnik R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 1994; 77: 325-8.
8. Baumruker T, Prieschl EE. Sphingolipids and the regulation of the immune response. Semin. Immunol. 2002; 14: 57-63.
9. Spiegel S. Sphingosine 1-phosphate: A prototype of a new class of second messengers. J. Leukoc. Biol. 1999; 65: 341-4.
10. Ott VL, Cambier JC. Introduction: Multifaceted roles of lipids and their catabolites in immune cell signaling. Semin. Immunol. 2002; 14: 1-6.
11. Olivera A, Spiegel S. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature 1993; 365: 557-60.
12. Meyer zu Heringdorf D, Lass H, Kuchar I et al. Role of sphingosine kinase in Ca(2+) signalling by epidermal growth factor receptor. FEBS Lett. 1999; 461: 217-22.
13. Xia P, Gamble JR, Rye KA et al. Tumor necrosis factor-alpha induces adhesion molecule expression through the sphingosine kinase pathway. Proc. Natl Acad. Sci. USA 1998; 95: 14 196-201.
14. Alemany R, Meyer zu Heringdorf D, Koppen CJ, Jakobs KH. Formyl peptide receptor signaling in HL-60 cells through sphingosine kinase. J. Biol. Chem. 1999; 274: 3994-9.
15. i-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J. Cell Biol. 1998; 142: 229-40.
16. Meyer zu Heringdorf D, van Koppen CJ, Jakobs KH. Molecular diversity of sphingolipid signalling. FEBS Lett. 1997; 410: 34-8.
17. Olivera A, Edsall L, Poulton S, Kazlauskas A, Spiegel S. Platelet-derived growth factor-induced activation of sphingosine kinase requires phosphorylation of the PDGF receptor tyrosine residue responsible for binding of PLCgamma. FASEB J. 1999; 13: 1593-600.
18. Bornfeldt KE, Graves LM, Raines EW et al. Sphingosine-1-phosphate inhibits PDGF-induced chemotaxis of human arterial smooth muscle cells: Spatial and temporal modulation of PDGF chemotactic signal transduction. J. Cell Biol. 1995; 130: 193-206.
19. Choi OH, Kim JH, Kinet JP. Calcium mobilization via sphingosine kinase in signalling by the FcεRI antigen receptor. Nature 1996; 380: 634-6.
20. 2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells. J. Biol. Chem. 2002; 277: 17 255-62.
21. Melendez AJ, Floto RA, Gillooly DJ, Harnett MM, Allen JM. FcγRI coupling to phospholipase D initiates sphingosine kinase mediated calcium mobilization and vesicular trafficking. J. Biol. Chem. 1998; 273: 9393-402.
22. English D, Welch Z, Kovala AT et al. Sphingosine 1-phosphate released from platelets during clotting accounts for the potent endothelial cell chemotactic activity of blood serum and provides a novel link between hemostasis and angiogenesis. FASEB J. 2000; 14: 2255-65.
23. 2+ signals enzyme release, cytokine production, and chemotaxis. J. Immunol. 2004; 173: 1596-603.
24. Ibrahim FBM, Pang S-J, Melendez AJ. Anaphylatoxin signaling in human neutrophils: A key role for sphingosine kinase. J. Biol. Chem. 2004; 279: 44 802-11.
25. Kimura T, Sato K, Kuwabara A et al. Sphingosine 1-phosphate may be a major component of plasma lipoproteins responsible for the cytoprotective actions in human umbilical vein endothelial cells. J. Biol. Chem. 2001; 276: 31 780-5.
26. Hla T, Lee MJ, Ancellin N, Paik JH, Kluk MJ. Lysophospholipids: Receptor revelations. Science 2001; 294: 1875-8.
27. Goetzl EJ, An S. Diversity of cellular receptors and functions for the lysophospholipid growth factors lysophosphatidic acid and sphingosine 1-phosphate. FASEB J. 1998; 12: 1589-98.
28. An S, Goetzl EJ, Lee H. Signaling mechanisms and molecular characteristics of G protein-coupled receptors for lysophosphatidic acid and sphingosine 1-phosphate. J. Cell. Biochem. Suppl. 1998; 30/31: 147-57.
29. English D, Garcia JG, Brindley DN. Platelet-released phospholipids link haemostasis and angiogenesis. Cardiovasc. Res. 2001; 49: 588-99.
30. Kon J, Sato K, Watanabe T et al. Comparison of intrinsic activities of the putative sphingosine 1-phosphate receptor subtypes to regulate several signaling pathways in their cDNA-transfected Chinese hamster ovary cells. J. Biol. Chem. 1999; 274: 23 940-7.
31. Lee H, Liao JJ, Graeler M, Huang MC, Goetzl EJ. Lysophospholipid regulation of mononuclear phagocytes. Biochim. Biophys. Acta 2002; 1582: 175-7.
32. Van Brocklyn JR, Behbahani B, Lee NH. Homodimerization and heterodimerization of S1P/EDG sphingosine-1-phosphate receptors. Biochim. Biophys. Acta 2002; 1582: 89-93.
33. Lee MJ, Van Brocklyn JR, Thangada S et al. Sphingosine-1-phosphate as a ligand for the G protein-coupled receptor EDG-1. Science 1998; 279: 1552-5.
34. Zhang H, Desai NN, Olivera A, Seki T, Brooker G, Spiegel S. Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation. J. Cell Biol. 1991; 114: 155-67.
35. Zhang Q, Peyruchaud O, French KJ, Magnusson MK, Mosher DF. Sphingosine 1-phosphate stimulates fibronectin matrix assembly through a Rho-dependent signal pathway. Blood 1999; 93: 2984-90.
36. Lee MJ, Thangada S, Claffey KP et al. Vascular endothelial cell adherens junction assembly and morphogenesis induced by sphingosine-1-phosphate. Cell 1999; 99: 301-12.
37. Cuvillier O, Pirianov G, Kleuser B et al. Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate. Nature 1996; 381: 800-3.
38. Liu H, Chakravarty D, Maceyka M, Milstien S, Spiegel S. Sphingosine kinases: A novel family of lipid kinases. Prog. Nucleic Acid Res. 2002; 71: 493-511.
39. Kohama T, Olivera A, Edsall L, Nagiec MM, Dickson R, Spiegel S. Molecular cloning and functional characterization of murine sphingosine kinase. J. Biol. Chem. 1998; 273: 23 722-8.
40. Liu H, Sugiura M, Nava VE et al. Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform. J. Biol. Chem. 2000; 275: 19 513-20.
41. Birchwood CJ, Saba JD, Dickson RC, Cunningham KW. Calcium influx and singaling in yeast stimulated by intracellular sphingosine 1-phosphate accumulation. J. Biol. Chem. 2001; 276: 11 712-18.
42. Lanterman MM, Saba JD. Characterization of sphingosine kinase (SK) activity in Saccharomyces cerevisiae and isolation of SK-deficient mutants. Biochem. J. 1998; 332: 525-31.
43. Nagiec MM, Skrzypek M, Nagiec EE, Lester RL, Dickson RC. The LCB4 (YOR171c) and LCB5 (YLR260w) genes of Saccharomyces encode sphingoid long chain base kinases. J. Biol. Chem. 1998; 273: 19437-42.
44. Wang S, Banno Y, Nozawa Y. Two forms of membrane-bound sphingosine kinase in Tetrahymena and activity changes during growth and the cell cycle. J. Eukaryot. Microbiol. 2002; 49: 305-11.
45. Coursol S, Fan LM, Le Stunff H, Spiegel S, Gilroy S, Assmann SM. Sphingolipid signalling in Arabidopsis guard cells involves heterotrimeric G proteins. Nature 2003; 423: 651-4.
46. Nishiura H, Tamura K, Morimoto Y, Imai H. Characterization of sphingolipid long-chain base kinase in Arabidopsis thaliana. Biochem. Soc. Trans. 2000; 28: 747-8.
47. Spiegel S, Milstien S. Sphingosine 1-phosphate, a key cell signaling molecule. J. Biol. Chem. 2002; 277: 25 851-4.
48. Herr DR, Fyrst H, Creason MB, Plan VH, Saba JD, Harris GL. Characterization of the Drosophila sphingosine kinases and requirement for Sk2 in normal reproductive function. J. Biol. Chem. 2004; 279: 12 685-94.
49. Melendez AJ, Carlos-Dias E, Gosink M, Allen JM, Takacs L. Human sphingosine kinase: Molecular cloning, functional characterization and tissue distribution. Gene 2000; 251: 19-26.
50. Labesse G, Dougert D, Assairi L, Gilles AM. Diacylglyceride kinases, sphingosine kinases and NAD kinases: Distant relatives of 6- phosphofructokinases. Trends Biochem. Sci. 2002; 27: 273-5.
51. Olivera A, Kohama T, Tu ZX, Milstien S, Spiegel S. Purification and characterization of rat kidney sphingosine kinase. J. Biol. Chem. 1998; 273: 12 576-83.
52. Pitson SM, Moretti PA, Zebol JR et al. The nucleotide-binding site of human sphingosine kinase 1. J. Biol. Chem. 2002; 277: 49 545-53.
53. Pitson SM, D'Andrea RJ, Vandeleur L et al. Human sphingosine kinase: Purification, molecular cloning and characterization of the native and recombinant enzymes. Biochem. J. 2000; 350: 429-41.
54. Billich A, Bornancin F, Devay P, Mechtcheriakova D, Urtz N, Baumruker T. Phosphorylation of the immunomodulatory drug FTY720 by sphingosine kinases. J. Biol. Chem. 2003; 278: 47 408-15.
55. Fukuda Y, Kihara A, Igarashi Y. Distribution of sphingosine kinase activity in mouse tissues: Contributiona of SPHK1. Biochem. Biophys. Res. Commun. 2003; 309: 155-60.
56. Buehrer BM, Bell RM. Sphingosine kinase: Properties and cellular functions. Adv. Lipid Res. 1993; 26: 59-67.
57. Edsall LC, Van Brocklyn JR, Cuvillier O, Kleuser B, Spiegel S. N,N-Dimethylsphingosine is a potent competitive inhibitor of sphingosine kinase but not of protein kinase C: Modulation of cellular levels of sphingosine 1-phosphate and ceramide. Biochemistry 1998; 37: 12 892-8.
58. Gijsbers S, Van der Hoeven G, Van Veldhoven PP. Subcellular study of sphingoid base phosphorylation in rat tissues: Evidence for multiple sphingosine kinases. Biochim. Biophys. Acta 2001; 1532: 37-50.
59. Banno Y, Kato M, Hara A, Nozawa Y. Evidence for the presence of multiple forms of Sph kinase in human platelets. Biochem. J. 1998; 15: 301-4.
60. Murate T, Banno Y, T-Koizumi K et al. Cell type-specific localization of sphingosine kinase 1a in human tissues. J. Histochem. Cytochem. 2001; 49: 845-55.
61. 2+/calmodulin- dependent translocation of sphingosine kinase: Role in plasma membrane relocation but not activation. Cell Calcium 2003; 33: 119-28.
62. Igarashi N, Okada T, Hayashi S, Fujita T, Jahangeer S, Nakamura S. Sphingosine kinase 2 is a nuclear protein and inhibits DNA synthesis. J. Biol. Chem. 2003; 278: 46 832-9.
63. Ancellin N, Colmont C, Su J et al. Extracellular export of sphingosine kinase-1 enzyme. Sphingosine 1-phosphate generation and the induction of angiogenic vascular maturation. J. Biol. Chem. 2002; 277: 6667-75.
64. Edsall LC, Pirianov G, Spiegel S. Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J. Neurosci. 1997; 17: 6952-60.
65. Shu X, Wu W, Mosteller RD, Broek D. Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases. Mol. Cell. Biol. 2002; 22: 7758-68.
66. 3 inhibits programmed cell death in HL-60 cells by activation of sphingosine kinase. Cancer Res. 1998; 58: 1817-24.
67. Rius RA, Edsall LC, Spiegel S. Activation of sphingosine kinase in pheochromocytoma PC12 neuronal cells in response to trophic factors. FEBS Lett. 1997; 417: 173-6.
68. Melendez AJ, Gilloly DJ, Harnett MM, Allen JM. Aggregation of the human high: affinity immunoglobulin G receptor (FcgammaRI) activates both. Proc. Natl Acad. Sci. USA 1998; 95: 2169-74.
69. Pyne S, Pyne NJ. Sphingosine 1-phosphate signalling in mammalian cells. Biochem. J. 2000; 349: 385-402.
70. Sukocheva OA, Wang L, Albanese N, Vadas MA, Xia P. Sphingosine kinase transmits estrogen signaling in human breast cancer cells. Mol. Endocrinol. 2003; 17: 2002-12.
71. Olivera A, Spiegel S. Sphingosine kinase: A mediator of vital cellular functions. Prostaglandins Other Lipid Mediat. 2001; 64: 123-34.
72. Johnson KR, Becker KP, Facchinetti MM, Hannun YA, Obeid LM. PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane, extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA). J. Biol. Chem. 2002; 277: 35 257-62.
73. Pitson SM, Moretti PA, Zebol JR et al. Activation of sphingosine kinase 1 by ERK1/2-mediated phosphorylation. EMBO J. 2003; 22: 5491-500.
74. Melendez A, Floto RA, Cameron AJ, Gilloly DJ, Harnett MM, Allen JM. A molecular switch changes the signalling pathway used by the Fc gamma RI antibody receptor to mobilise calcium. Curr. Biol. 1998; 8: 210-21.
75. 2+ signaling and phagosome maturation in human macrophages via specific inhibition of sphingosine kinase. J. Immunol. 2003; 170: 2811-15.
76. Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 2000; 1: 11-21.
77. Bootman MD, Berridge MJ, Roderick HL. Calcium signalling: More messengers, more channels, more complexity. Curr. Biol. 2002; 12: R563-5.
78. 2+ signals. J. Cell Sci. 2001; 114: 2213-22.
79. 2+ in late endosome-lysosome heterotypic fusion and in the reformation of lysosomes from hybrid organelles. J. Cell Biol. 2000; 149: 1053-62.
80. Tapper H. The secretion of preformed granules by macrophages and neutrophils. J. Leukoc. Biol. 1996; 59: 613-22.
81. Brumell JH, Volchuk A, Sengelov H et al. Subcellular distribution of docking/fusion proteins in neutrophils, secretory cells with multiple exocytic compartments. J. Immunol. 1995; 155: 5750-9.
82. 2+ oscillations in differentiated U937 cells: A study using laser scanning confocal microscopy and co-loaded Fluo-3 and Fura-red fluorescent probes. Cell Calcium 1995; 18: 377-89.
83. Mandeville JT, Maxfield FR. Calcium and signal transduction in granulocytes. Curr. Opin. Hematol. 1996; 3: 63-70.
84. 2+/calmodulin signals the completion of docking and triggers a late step of vacuole fusion. Nature 1998; 396: 575-80.
85. 2+ during phagolysosome formation? Cell Calcium 2000; 27: 353-62.
86. Berridge MJ. Inositol trisphosphate and calcium signalling. Nature 1993; 361: 315-25.
87. Rosales C, Brown EJ. Signal transduction by neutrophil immunoglobulin G Fc receptors: Dissociation of intracytoplasmic calcium concentration rise from inositol 1,4,5-trisphosphate. J. Biol. Chem. 1992; 267: 5265-71.
88. Melendez AJ, Bruetschy L, Floto RA, Harnett MM, Allen JM. Functional coupling of FcγRI to nicotinamide dinucleotide phosphate (reduced form) oxidative burst and immune complex trafficking requires the activation of phospholipase D1. Blood 2001; 98: 3421-8.
89. 2+ in human neutrophils. Proc. Natl Acad. Sci. USA 1994; 91: 3534-8.
90. Olivera A, Rosenthal J, Spiegel S. Effect of acidic phospholipids on sphingosine kinase. J. Cell. Biochem. 1996; 60: 529-37.
91. Kawa S, Kimura S, Hakomori S, Igarashi Y. Inhibition of chemotactic motility and trans-endothelial migration of human neutrophils by sphingosine 1-phosphate. FEBS Lett. 1997; 420: 196-200.
92. Yatomi Y, Igarashi Y, Yang L et al. Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. J. Biochem. 1997; 121: 969-73.
93. Hla T, Maciag T. An abundant transcript induced in differenciating human endothelial cells encodes a polypeptide with structural similarities to G-protein-coupled receptors. J. Biol. Chem. 1990; 265: 9308-13.
94. Ozaki H, Hla T, Lee MJ. Sphingosine-1-phosphate signaling in endothelial activation. J. Atheroscler. Thromb. 2003; 10: 125-31.
95. Rönnstrand L, Heldin CH. Mechanisms of platelet-derived growth factor-induced chemotaxis. Int. J. Cancer 2001; 91: 757-62.
96. Vaux DL & Strasser A. The molecular biology of apoptosis. Proc. Natl Acad. Sci. USA 1996; 93: 2239-44.
97. Cuvillier O. Sphingosine in apoptosis signaling. Biochim. Biophys. Acta 2002; 1585: 153-62.
98. Maceyka M, Payne SG, Milstien S, Spiegel S. Sphingosine kinase, sphingosine-1-phosphate, and apoptosis. Biochim. Biophys. Acta 2002; 1585: 193-201.
99. Olivera A, Kohama T, Edsall L et al. Sphingosine kinase expression increase intracellular sphingosine-1-phosphate and promotes cell growth and survival. J. Cell Biol. 1999; 147: 545-58.
100. Edsall LC, Cuvillier O, Twitty S, Spiegel S, Milstien S. Sphingosine kinase expression regulates apoptosis and caspase activation in PC12 cells. J. Neurochem. 2001; 76: 1573-84.
101. Rosenfeldt HM, Hobson JP, Maceyka M et al. EDG-1 links the PDGF receptor to Src and focal adhesion kinase activation leading to lamellipodia formation and cell migration. FASEB J. 2001; 15: 2649-59.
102. Kaneider NC, Dianani A, Fischer-Colbrie R, Wiedermann CJ. Sphingosine kinase-dependent directional migration of leukocytes in response to phorbol ester. Biochem. Biophys. Res. Commun. 2002; 297: 806-10.
103. Van Brocklyn JR, Young N, Roof R. Sphingosine-1-phosphate stimulates motility and invasiveness of human glioblastoma multiforme cells. Cancer Lett. 2003; 10: 53-60.
104. Zhang X, Kluger Y, Nakayama Y et al. Gene expression in mature neutrophils: Early responses to inflammatory stimuli. J. Leukoc. Biol. 2004; 75: 358-72.
105. MacKinnon AC, Buckley A, Chilvers ER, Rossi AG, Haslett C, Sethi T. Sphingosine kinase: A point of convergence in the action of diverse neutrophil priming agents. J. Immunol. 2002; 169: 6394-400.
106. Niwa M, Kozawa O, Matsuno H, Kanamori Y, Hara A, Uematsu T. Tumor necrosis factor-alpha-mediated signal transduction in human neutrophils: Involvement of sphingomyelin metabolites in the priming effect of TNF-alpha on the fMLP-stimulated Superoxide production. Life Sci. 2000; 66: 245-56.
107. Rosenfeld ME, Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Arteriosclerosis 1990; 10: 680-7.
108. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C. Macrophages and angiogenesis. J. Leukoc. Biol. 1994; 55: 410-22.
109. Russell DG. Mycobacterium tuberculosis: Here today, and here tomorrow. Nat. Rev. Mol. Cell. Biol. 2001; 2: 569-77.
110. Beaven MA. Calcium signalling: Sphingosine kinase versus phospholipase C. Curr. Biol. 1996; 6: 798-801.
111. Beaven MA, Baumgartner RA. Downstream signals initiated in mast cells by Fc epsilon RI and other receptors. Curr. Opin. Immunol. 1996; 8: 766-72.
112. Galli SJ, Wershil BK. The two faces of the mast cell. Nature 1996; 381: 21-2.
113. Prieschl EE, Csonga R, Novotny V, Kikuchi GE, Baumruker T. The balance between sphingosine and sphingosine-1-phosphate is decisive for mast cell activation after Fcε receptor I triggering. J. Exp. Med. 1999; 190: 1-8.
114. Yoshimoto T, Furuhata M, Kamiya S et al. Positive modulation of IL-12 signaling by sphingosine kinase 2 associating with the IL-12 receptor beta 1 cytoplasmic region. J. Immunol. 2003; 171: 1352-9.
115. Yatomi Y, Ruan F, Hakomon S, Igarashi Y. Sphingosine-1-phosphate: A platelet-activating sphingolipid released from agonist-stimulated human platelets. Blood 1995; 86: 193-202.
116. Jolly PS, Rosenfeldt HM, Milstein S, Spiegel S. The roles of sphingosine-1-phosphate in asthma. Mol. Immunol. 2002; 38: 1239-45.
117. Williams CS, Mann M, DuBois RN. The role of cyclooxygenases in inflammation, cancer, and development. Oncogene 1999; 18: 7908-16.
118. Takaku K, Sonoshita M, Sasaki N et al. Suppression of intestinal polyposis in Apc(delta 716) knockout mice by an additional mutation in the cytosolic phospholipase A(2) gene. J. Biol. Chem. 2000; 275: 34013-16.
119. Kuokkanen S, Gschwend M, Rioux JD et al. Genomewide scan of multiple sclerosis in Finnish multiplex families. Am. J. Hum. Genet. 1997; 61: 1379-87.
120. Nair RP, Henseler T, Jenisch S et al. Evidence for two psoriasis susceptibility loci (HLA and 17q) and two novel candidate regions (16q and 20p) by genome-wide scan. Hum. Mol. Genet. 1977; 8: 1349-56.
121. Enlund F, Samuelsson L, Enerback C et al. Analysis of three suggested psoriasis susceptibility loci in a large Swedish set of families: Confirmation of linkage to chromosome 6p (HLA region) and to 17q, but not to 4q. Hum. Hered. 1999; 1: 2-8.